Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // December 4th, 2008 // 6:10 am
Hello, everyone, and welcome to Thursday. First, we would like to apologize for our absence yesterday afternoon, but we had an important meeting that kept us from our laptop. Hard to believe, yes? Now, though, we are back, as you can see, and have gathered some interesting items for you to digest as we shuttle our short people to their schoolhouses. Have a good day…
Bristol-Myers Cuts DeWitt Workforce (Central New York Business Journal)
Cigna Cuts Lipitor Cost By Half (Bloomberg News)
FDA Panel Backs Novartis Malaria Drug (Reuters)
Extended Treatment For Hepatitis C Is Challenged (The New York Times)
Sepracor Gets Tax Break In Massachusetts (MetroWest Daily)
FDA Wants More Data On Roche’s Actemra (PharmaTimes)
KV Pharmaceuticals Sued By Shareholders (St. Louis Business Journal)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Bristol Myers Squibb, Cigna, coartem, DeWitt, Hepatitis C, KV Pharmaceutical, Lipitor, Novartis, Pegasys, Pfizer, Roche